Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 47.70M | 47.55M | 42.11M | 42.09M | 34.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.70M | 47.55M | 42.11M | 42.09M | 34.60M |
| Cost of Revenue | 21.79M | 21.72M | 19.68M | 19.68M | 17.52M |
| Gross Profit | 25.90M | 25.82M | 22.42M | 22.42M | 17.07M |
| SG&A Expenses | 21.02M | 20.95M | 17.24M | 17.23M | 16.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.59M | -2.58M | -1.28M | -1.28M | -2.63M |
| Total Operating Expenses | 43.42M | 43.28M | 37.82M | 37.80M | 34.37M |
| Operating Income | 4.28M | 4.26M | 4.29M | 4.29M | 232.70K |
| Income Before Tax | 2.38M | 2.37M | 3.91M | 3.91M | 230.20K |
| Income Tax Expenses | 1.50M | 1.49M | 399.00K | 398.90K | 291.60K |
| Earnings from Continuing Operations | 883.90K | 881.10K | 3.51M | 3.51M | -61.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.09M | 1.08M | 486.70K | 486.50K | 98.60K |
| Net Income | 1.97M | 1.96M | 4.00M | 3.99M | 37.20K |
| EBIT | 4.28M | 4.26M | 4.29M | 4.29M | 232.70K |
| EBITDA | 5.32M | 5.31M | 8.79M | 8.79M | 1.31M |
| EPS Basic | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Average Basic Shares Outstanding | 588.84M | 588.84M | 588.84M | 588.84M | 588.84M |
| Average Diluted Shares Outstanding | 588.84M | 588.84M | 588.84M | 588.84M | 588.84M |
| Dividend Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payout Ratio | 38.46% | 38.46% | 9.42% | 9.42% | 810.84% |